| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2020-02-18 | ALLIANCEBERNSTEIN L.P. | Zeltiq Aesthetics Inc | 0 | 0.0% | EDGAR |
| SC 13G/A | 2018-02-14 | Capital World Investors | Zeltiq Aesthetics Inc | - | 0.0% | EDGAR |
| SC 13G/A | 2017-03-10 | FMR LLC | Zeltiq Aesthetics Inc | 22 | 0.0% | EDGAR |
| SC 13G/A | 2017-02-14 | FMR LLC | Zeltiq Aesthetics Inc | 5,996,556 | 15.0% | EDGAR |
| SC 13G/A | 2017-02-14 | Point72 Asset Management, L.P. | Zeltiq Aesthetics Inc | 125,506 | 0.3% | EDGAR |
| SC 13G/A | 2017-02-14 | Visium Asset Management, LP | Zeltiq Aesthetics Inc | 0 | 0.0% | EDGAR |
| SC 13G/A | 2017-02-13 | Capital World Investors | Zeltiq Aesthetics Inc | 3,122,044 | 7.8% | EDGAR |
| SC 13G | 2017-02-10 | VANGUARD GROUP INC | Zeltiq Aesthetics Inc | 2,384,670 | 6.0% | EDGAR |
| SC 13G | 2017-02-10 | ALLIANCEBERNSTEIN L.P. | Zeltiq Aesthetics Inc | 2,019,990 | 5.1% | EDGAR |
| SC 13G | 2017-01-09 | BlackRock Inc. | Zeltiq Aesthetics Inc | 4,084,079 | 10.2% | EDGAR |
| SC 13G/A | 2016-07-11 | FMR LLC | Zeltiq Aesthetics Inc | 4,277,811 | 10.8% | EDGAR |
| SC 13G/A | 2016-03-10 | LORD, ABBETT & CO. LLC | Zeltiq Aesthetics Inc | 1,427,606 | 3.7% | EDGAR |
| SC 13G/A | 2016-03-08 | Frazier Healthcare V, LP | Zeltiq Aesthetics Inc | - | - | EDGAR |
| SC 13G/A | 2016-02-16 | Point72 Asset Management, L.P. | Zeltiq Aesthetics Inc | 2,319,887 | 5.9% | EDGAR |
| SC 13G/A | 2016-02-16 | LORD, ABBETT & CO. LLC | Zeltiq Aesthetics Inc | 2,522,165 | 6.5% | EDGAR |
| SC 13G/A | 2016-02-16 | Capital World Investors | Zeltiq Aesthetics Inc | 3,002,044 | 7.6% | EDGAR |
| SC 13G/A | 2016-02-12 | FMR LLC | Zeltiq Aesthetics Inc | 2,665,700 | 6.8% | EDGAR |
| SC 13G/A | 2016-02-12 | Visium Asset Management, LP | Zeltiq Aesthetics Inc | 2,182,528 | 5.6% | EDGAR |
| SC 13G | 2015-11-30 | Visium Asset Management, LP | Zeltiq Aesthetics Inc | 1,954,927 | 5.0% | EDGAR |
| SC 13D/A | 2015-11-20 | AISLING CAPITAL III LP | Zeltiq Aesthetics Inc | 2,353,734 | 6.0% | EDGAR |